Structure, function, and activation of coagulation factor VII

被引:39
作者
Eigenbrot, C [1 ]
机构
[1] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
关键词
D O I
10.2174/1389203023380675
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor VII is the coagulation protease responsible for starting a cascade of proteolytic events that lead to thrombin generation, fibrin deposition, and platelet activation. As such, FVII has attracted wide interest as a target for clinical anti-coagulant applications. Commensurate with the critical importance of,maintaining balance between thrombosis and hemostasis and its place at the beginning of the coagulation process, FVII is subject to a variety of biological and biochemical control mechanisms, among them allosteric influences exerted by cofactors, substrates, and inhibitors. Sites on FVIIa where allosteric influences are exerted and manifested have been identified and characterized in considerable detail. In recent years, a three-dimensional context for the interpretation of these results has become available from structural studies. New X-ray structures have augmented specific aspects of our understanding, in particular the X-ray structure of a fragment of the FVII zymogen. This review summarizes general allosteric behaviors of FVIIa and recapitulates structural findings since 1996, with particular emphasis on the recently determined zymogen structure.
引用
收藏
页码:287 / 299
页数:13
相关论文
共 70 条
[1]   FACTOR-VII BINDING TO TISSUE FACTOR IN RECONSTITUTED PHOSPHOLIPID-VESICLES - INDUCTION OF COOPERATIVITY BY PHOSPHATIDYLSERINE [J].
BACH, R ;
GENTRY, R ;
NEMERSON, Y .
BIOCHEMISTRY, 1986, 25 (14) :4007-4020
[2]   The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor [J].
Banner, DW ;
DArcy, A ;
Chene, C ;
Winkler, FK ;
Guha, A ;
Konigsberg, WH ;
Nemerson, Y ;
Kirchhofer, D .
NATURE, 1996, 380 (6569) :41-46
[3]   THE CONTRIBUTIONS OF CA-2+, PHOSPHOLIPIDS AND TISSUE-FACTOR APOPROTEIN TO THE ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-X BY ACTIVATED FACTOR-VII [J].
BOM, VJJ ;
BERTINA, RM .
BIOCHEMICAL JOURNAL, 1990, 265 (02) :327-336
[4]   X-RAY STRUCTURE OF CLOTTING FACTOR IXA - ACTIVE-SITE AND MODULE STRUCTURE RELATED TO XASE ACTIVITY AND HEMOPHILIA-B [J].
BRANDSTETTER, H ;
BAUER, M ;
HUBER, R ;
LOLLAR, P ;
BODE, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9796-9800
[5]   X-ray structure of active site-inhibited clotting factor Xa - Implications for drug design and substrate recognition [J].
Brandstetter, H ;
Kuhne, A ;
Bode, W ;
Huber, R ;
vonderSaal, W ;
Wirthensohn, K ;
Engh, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :29988-29992
[6]   SYNTHETIC SUBSTRATES FOR HUMAN FACTOR-VIIA AND FACTOR-VIIA-TISSUE FACTOR [J].
BUTENAS, S ;
RIBARIK, N ;
MANN, KG .
BIOCHEMISTRY, 1993, 32 (26) :6531-6538
[7]   Kinetics of human factor VII activation [J].
Butenas, S ;
Mann, KG .
BIOCHEMISTRY, 1996, 35 (06) :1904-1910
[8]   THE 1ST EPIDERMAL GROWTH-FACTOR DOMAIN OF HUMAN COAGULATION FACTOR-VII IS ESSENTIAL FOR BINDING WITH TISSUE FACTOR [J].
CLARKE, BJ ;
OFOSU, FA ;
SRIDHARA, S ;
BONA, RD ;
RICKLES, FR ;
BLAJCHMAN, MA .
FEBS LETTERS, 1992, 298 (2-3) :206-210
[9]  
Creighton T.E., 1984, Proteins: Structure and Molecular Properties
[10]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370